Radiopharm Theranostics Ltd
RAD
Company Profile
Business description
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Contact
62 Lygon Street
Level 3, Carlton South
MelbourneVIC3053
AUST: +61 398245254
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Oracle shares are up 87% in 2025. Is it a buy?
Oracle’s cloud database business is riding the AI wave.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,057.60 | 48.70 | -0.53% |
| CAC 40 | 7,826.35 | 45.67 | -0.58% |
| DAX 40 | 23,559.57 | 51.76 | -0.22% |
| Dow JONES (US) | 46,292.78 | 88.76 | -0.19% |
| FTSE 100 | 9,209.44 | 13.88 | -0.15% |
| HKSE | 26,518.65 | 359.53 | 1.37% |
| NASDAQ | 22,573.47 | 215.50 | -0.95% |
| Nikkei 225 | 45,630.31 | 136.65 | 0.30% |
| NZX 50 Index | 13,181.31 | 44.77 | 0.34% |
| S&P 500 | 6,656.92 | 36.83 | -0.55% |
| S&P/ASX 200 | 8,764.50 | 50.50 | -0.57% |
| SSE Composite Index | 3,853.64 | 31.81 | 0.83% |